Journal of Clinical Oncology | 2019

A circulating tumor cell specific RNA assay for assessment of androgen receptor signaling inhibitor sensitivity in metastatic castration-resistant prostate cancer.

 
 
 
 
 
 
 
 
 
 
 
 

Abstract


5059Background: Our objective is to develop a circulating tumor cell (CTC)-RNA assay for characterizing clinically relevant RNA signatures for the assessment of androgen receptor signaling inhibito...

Volume 37
Pages 5059-5059
DOI 10.1200/JCO.2019.37.15_SUPPL.5059
Language English
Journal Journal of Clinical Oncology

Full Text